EP, USP, CP 99%+ farin foda 10-DAB paclitaxel API

Takaitaccen Bayani:

Paclitaxel wakili ne na chemotherapeutic taxoid da ake amfani dashi azaman layin farko da na gaba don maganin ci-gaban carcinoma na ovary, da sauran cututtukan daji daban-daban ciki har da kansar nono da huhu.An yi amfani da Paclitaxel APIs sosai a cikin alluran rigakafin ciwon daji, irin su allurar man fetur na polyoxyethylene castor, alluran liposome, allurar albumin, da maganin baka.Hakanan ana amfani da shi a cikin ƙwayar ƙwayar cuta ta Drug eluting stent da balloons masu rufaffiyar ƙwayoyi don magance cututtukan cututtukan zuciya da cututtukan jijiyoyin jini.


Cikakken Bayani

Tags samfurin

Bayanan Samfura

An kafa shi a cikin 1993, Yunnan Hande bio-tech Co., Ltd. shine babban mai kera Paclitaxel APIs wanda ya shahara a duniya, kamfanin da ke Kunming, Yunnan, PR China, mallakin China GMP takardar shaidar, CEP, kuma Amurka ta amince da shi. FDA da TGA, kuma sun shiga Burtaniya, Indiya, Japan, Kanada, Singapore, Koriya ta Kudu, China China, Malaysia, Rasha, Turkiyya da Zimbabwe, a cikin bayanan.

Sabuwar ginin ginin ya ƙunshi yanki mai girman eka 20 tare da gine-ginen masana'anta sama da murabba'in murabba'in mita 10,000.Kayan aiki sun haɗa da dakin gwaje-gwaje na kasa da kasa, mai rufe ruwa, gas, abubuwan ƙarfe, infrared, microbes, ƙayyadaddun danshi, Duk abubuwan dubawa kamar binciken kwanciyar hankali, ta amfani da kayan gwaji duka-cikin-ɗaya, cikakken tsarin amincin IT, ingantaccen & cikakken rufewa. layin samar da rabuwa da tsarkakewa, da gine-ginen masana'anta mai tsabta.Ƙarfin samar da kamfani na paclitaxel na halitta ya karu zuwa 500kg a kowace shekara, 10-DAB III ya karu zuwa 1000kg a kowace shekara.

An yi amfani da APIs na paclitaxel na kamfanin a cikin alluran rigakafin ciwon daji na abokan ciniki, irin su allurar man fetur na polyoxyethylene castor, injections na liposome, allurar albumin, da maganin baka.Hakanan ana amfani da shi a cikin ƙwayar ƙwayar cuta ta Drug eluting stent da balloons masu rufaffiyar ƙwayoyi don magance cututtukan cututtukan zuciya da cututtukan jijiyoyin jini.Domin shekaru 28, Hande ya ci gaba da samar da samfurori na musamman ga abokan ciniki a matakai daban-daban kamar R&D, ƙaramin gwaji, gwajin matukin jirgi, da rukunin kasuwanci.

Sigar Samfura

BAYANIN KAMFANI
Sunan samfur 10-DAB Semi-Synthetic Paclitaxel, APIs
CAS 33069-62-4
Tsarin sinadarai Saukewa: C47H51NO14
Brand Hkuma
Mmaƙera Yunnan Hande Bio-Tech Co., Ltd.
Czance Kunming,China
An kafa 1993
BBAYANIN ASIC
Makamantu TAXOL®Paclitaxel, Taxus sp.Baccatin III N-benzyl-beta-phenylisoserine EsterSCHEMBL12202822.beta.-(Benzoylamino)-.alpha.-hydroxy-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2aR,3, 4S,4aS,5,6R,9S,10,11S,12S,12aR,12bS-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H- cyclodeca [3,4] benz [1,2-b] oxet-9-yl ester, benzenepropanoic acid.
Nau'in Karamin Kwayoyin Halitta
Tsarin  3
Nauyi Matsakaici: 853.9061Monoisotopic: 853.330955345
HS Code 29329990.21
inganciSpecification Ph.Yuro, CP, USP, IP
Ctakardun shaida Mallakar China GMP takardar shaidar, CEP, kuma Amurka FDA da TGA suka amince da su, kuma sun shiga Burtaniya, Indiya, Japan, Kanada, Singapore, Koriya ta Kudu, China China, Malaysia, Rasha, Turkiyya, da Zimbabwe, a cikin bayanan.
Assay 98.0% -102.0%
Bayyanar Fari ko kashe-Farin crystalline Foda
Hanyar Hakar Cire daga babban abun ciki Taxus wallichiana Zucc.Babban abun ciki mai tasiri na paclitaxel na yew ya fi 0.3‰.
Iyawar Shekara-shekara 600kg-800kg / shekara
Kunshin Marufi da yawa na DMF na ciki: kwalban gilashin Brown, Jakar Polyethylene, Jakar Foil
COA COA na musamman, Haɗu da ingancin buƙatun abokan ciniki daban-daban
Dabarun dabaru Da yawasufuris
PaymentTerms T/T, D/P, D/A
Oa can Karɓar binciken abokin ciniki koyaushe;Taimaka tare da rajista na tsari.

  • Na baya:
  • Na gaba: